DEMECLOCYCLINE ACETLAB 150 mg, hard capsule 100 capsules
Active ingredients: Demeclocycline hydrochloride, Demeclocycline
Commercialized according to BDPMDispensing in France: Prescription only
Hard capsule100 capsulesorale
No current ANSM shortage notice is included
Package details
Original BDPM fields are shown in French.
- Official name
- DEMECLOCYCLINE ACETLAB 150 mg, gélule
- Pharmaceutical form
- gélule
- Route of administration
- orale
- Presentation description
- 1 flacon(s) polyéthylène haute densité (PEHD) de 100 gélule(s)
- Marketing authorisation holder
- MITEM PHARMA
- Reimbursement according to BDPM
- 65%
- Approval for use in healthcare institutions
- oui
- Commercialization declaration date
- 17 May 2019
- Prescription and dispensing conditions
- Prescription only
- List I: prescription-only medicine
- Initial prescription by a hospital doctor
- Enhanced ANSM monitoring
- No
BDPM identifiers
CIS
65505630CIP73016684CIP133400930166840Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| CHLORHYDRATE DE DÉMÉCLOCYCLINEgélule | 161,81 mg · une gélule | SA |
| DÉMÉCLOCYCLINEgélule | 150 mg · une gélule | FT |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.
The published catalog does not list other packages of similar medicines.